These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 33429000)

  • 1. Initial impact of a national programme to contain the spread of carbapenemase-producing Enterobacterales in Ireland.
    Vellinga A; Brennan W; Humphreys H; Burns K
    J Hosp Infect; 2021 Mar; 109():107-114. PubMed ID: 33429000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring of hospital sewage shows both promise and limitations as an early-warning system for carbapenemase-producing Enterobacterales in a low-prevalence setting.
    Flach CF; Hutinel M; Razavi M; Åhrén C; Larsson DGJ
    Water Res; 2021 Jul; 200():117261. PubMed ID: 34082263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of hospital antimicrobial use on carbapenem-non-susceptible Enterobacterales incidence rates according to their mechanism of resistance: a time-series analysis.
    Ortiz-Brizuela E; Caro-Vega Y; Bobadilla-Del-Valle M; Leal-Vega F; Criollo-Mora E; López Luis BA; Esteban-Kenel V; Torres-Veintimilla E; Galindo-Fraga A; Olivas-Martínez A; Tovar-Calderón E; Torres-González P; Sifuentes-Osornio J; Ponce-de-León A
    J Hosp Infect; 2020 Aug; 105(4):757-765. PubMed ID: 32565368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolving epidemiology of carbapenemase-producing Enterobacterales: one hospital's infection prevention and control response over nine years.
    Foley M; Duffy F; Skally M; McCormack F; Finn C; O'Connor M; Cafferkey J; Thomas T; Burns K; Fitzpatrick F; O'Connell K; Smyth EG; Humphreys H
    J Hosp Infect; 2021 Jun; 112():61-68. PubMed ID: 33812939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detecting carbapenemase-producing Enterobacterales (CPE): an evaluation of an enhanced CPE infection control and screening programme in acute care.
    Otter JA; Mookerjee S; Davies F; Bolt F; Dyakova E; Shersing Y; Boonyasiri A; Weiße AY; Gilchrist M; Galletly TJ; Brannigan ET; Holmes AH
    J Antimicrob Chemother; 2020 Sep; 75(9):2670-2676. PubMed ID: 32479615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Disk carbapenemase test using improved disks for rapid detection and differentiation of clinical isolates of carbapenemase-producing Enterobacterales.
    Lee H; Kim JL; Jung DH; Seo Y; Kim M; Yong D; Lee K; Chong Y
    J Infect Chemother; 2021 Aug; 27(8):1205-1211. PubMed ID: 33888420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of enhanced screening for carbapenemase-producing Enterobacterales in an acute care hospital in South Korea.
    Park SH; Yi Y; Suh W; Ji SK; Han E; Shin S
    Antimicrob Resist Infect Control; 2023 Jul; 12(1):62. PubMed ID: 37400884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Irish outbreak of New Delhi metallo-β-lactamase (NDM)-1 carbapenemase-producing Enterobacteriaceae: increasing but unrecognized prevalence.
    O'Connor C; Cormican M; Boo TW; McGrath E; Slevin B; O'Gorman A; Commane M; Mahony S; O'Donovan E; Powell J; Monahan R; Finnegan C; Kiernan MG; Coffey JC; Power L; O'Connell NH; Dunne CP
    J Hosp Infect; 2016 Dec; 94(4):351-357. PubMed ID: 27624807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results from the Canadian Nosocomial Infection Surveillance Program on Carbapenemase-Producing Enterobacteriaceae, 2010 to 2014.
    Mataseje LF; Abdesselam K; Vachon J; Mitchel R; Bryce E; Roscoe D; Boyd DA; Embree J; Katz K; Kibsey P; Simor AE; Taylor G; Turgeon N; Langley J; Gravel D; Amaratunga K; Mulvey MR
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6787-6794. PubMed ID: 27600052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful control of the first OXA-48 and/or NDM carbapenemase-producing Klebsiella pneumoniae outbreak in Slovenia 2014-2016.
    Pirš M; Cerar Kišek T; Križan Hergouth V; Seme K; Mueller Premru M; Jeverica S; Logar M; Mrvič T; Žnidaršič B; Jordan Markočič O; Lejko Zupanc T
    J Hosp Infect; 2019 Feb; 101(2):142-149. PubMed ID: 30399389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of carbapenemase-producing Enterobacteriaceae in a low incidence area: A six-year experience in a university hospital.
    Emery A; Jeanvoine A; Bailly P; Gbaguidi-Haore H; Hocquet D; Bertrand X
    Infect Control Hosp Epidemiol; 2019 Aug; 40(8):936-938. PubMed ID: 31203818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of nine different selective agars for the detection of carbapenemase-producing Enterobacterales (CPE).
    Göttig S; Walker SV; Saleh A; Koroska F; Sommer J; Stelzer Y; Steinmann J; Hamprecht A
    Eur J Clin Microbiol Infect Dis; 2020 May; 39(5):923-927. PubMed ID: 31902017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term control of carbapenemase-producing Enterobacteriaceae at the scale of a large French multihospital institution: a nine-year experience, France, 2004 to 2012.
    Fournier S; Monteil C; Lepainteur M; Richard C; Brun-Buisson C; Jarlier V; Ap-Hp Outbreaks Control Group C
    Euro Surveill; 2014 May; 19(19):. PubMed ID: 24852956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistence of Klebsiella pneumoniae ST258 as the predominant clone of carbapenemase-producing Enterobacteriaceae in post-acute-care hospitals in Israel, 2008-13.
    Adler A; Hussein O; Ben-David D; Masarwa S; Navon-Venezia S; Schwaber MJ; Carmeli Y;
    J Antimicrob Chemother; 2015 Jan; 70(1):89-92. PubMed ID: 25204343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of strategies to control the spread of carbapenemase-producing Enterobacterales in hospitals: a modelling study.
    Kardaś-Słoma L; Fournier S; Dupont JC; Rochaix L; Birgand G; Zahar JR; Lescure FX; Kernéis S; Durand-Zaleski I; Lucet JC
    Antimicrob Resist Infect Control; 2022 Sep; 11(1):117. PubMed ID: 36117231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clearance of carbapenemase-producing Enterobacteriaceae (CPE) carriage: a comparative study of NDM-1 and KPC CPE.
    Lim YJ; Park HY; Lee JY; Kwak SH; Kim MN; Sung H; Kim SH; Choi SH
    Clin Microbiol Infect; 2018 Oct; 24(10):1104.e5-1104.e8. PubMed ID: 29870856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infection prevention and control policy implementation for CPE: a cross-sectional national survey of healthcare workers reveals knowledge gaps and suboptimal practices.
    Kearney A; Humphreys H; Fitzgerald-Hughes D
    J Hosp Infect; 2024 Mar; 145():148-154. PubMed ID: 38145813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbapenemase-producing Enterobacteriaceae in Europe: assessment by national experts from 38 countries, May 2015.
    Albiger B; Glasner C; Struelens MJ; Grundmann H; Monnet DL;
    Euro Surveill; 2015; 20(45):. PubMed ID: 26675038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and Molecular Characteristics of Carbapenemase-Producing Enterobacteriaceae From Five Hospitals in Korea.
    Jeong SH; Kim HS; Kim JS; Shin DH; Kim HS; Park MJ; Shin S; Hong JS; Lee SS; Song W
    Ann Lab Med; 2016 Nov; 36(6):529-35. PubMed ID: 27578505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular characteristics of carbapenemase-producing Enterobacterales in the Netherlands; results of the 2014-2018 national laboratory surveillance.
    van der Zwaluw K; Witteveen S; Wielders L; van Santen M; Landman F; de Haan A; Schouls LM; Bosch T;
    Clin Microbiol Infect; 2020 Oct; 26(10):1412.e7-1412.e12. PubMed ID: 32006688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.